MedPath

Incidence of immune checkpoint inhibitor-induced arthritis

Not Applicable
Conditions
Solid tumors
Registration Number
JPRN-UMIN000044972
Lead Sponsor
Yokohama City University Graduate School of Medicine
Brief Summary

Please refer to the following: Rheumatology (Oxford). 2022 Sep 7;keac519. doi: 10.1093/rheumatology/keac519. Online ahead of print.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14377
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath